These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 37124031)
1. Development of an anti- Horspool AM; Sen-Kilic E; Malkowski AC; Breslow SL; Mateu-Borras M; Hudson MS; Nunley MA; Elliott S; Ray K; Snyder GA; Miller SJ; Kang J; Blackwood CB; Weaver KL; Witt WT; Huckaby AB; Pyles GM; Clark T; Al Qatarneh S; Lewis GK; Damron FH; Barbier M Front Cell Infect Microbiol; 2023; 13():1117844. PubMed ID: 37124031 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies against lipopolysaccharide protect against Kang J; Mateu-Borrás M; Monroe HL; Sen-Kilic E; Miller SJ; Dublin SR; Huckaby AB; Yang E; Pyles GM; Nunley MA; Chapman JA; Amin MS; Damron FH; Barbier M Front Cell Infect Microbiol; 2023; 13():1191806. PubMed ID: 37424774 [No Abstract] [Full Text] [Related]
3. Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11. Horn MP; Zuercher AW; Imboden MA; Rudolf MP; Lazar H; Wu H; Hoiby N; Fas SC; Lang AB Antimicrob Agents Chemother; 2010 Jun; 54(6):2338-44. PubMed ID: 20308370 [TBL] [Abstract][Full Text] [Related]
4. MEDI3902 Correlates of Protection against Severe Pseudomonas aeruginosa Pneumonia in a Rabbit Acute Pneumonia Model. Le HN; Quetz JS; Tran VG; Le VTM; Aguiar-Alves F; Pinheiro MG; Cheng L; Yu L; Sellman BR; Stover CK; DiGiandomenico A; Diep BA Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29483116 [No Abstract] [Full Text] [Related]
5. Human monoclonal antibodies to Pseudomonas aeruginosa alginate that protect against infection by both mucoid and nonmucoid strains. Pier GB; Boyer D; Preston M; Coleman FT; Llosa N; Mueschenborn-Koglin S; Theilacker C; Goldenberg H; Uchin J; Priebe GP; Grout M; Posner M; Cavacini L J Immunol; 2004 Nov; 173(9):5671-8. PubMed ID: 15494518 [TBL] [Abstract][Full Text] [Related]
7. Identification of broadly protective human antibodies to Pseudomonas aeruginosa exopolysaccharide Psl by phenotypic screening. DiGiandomenico A; Warrener P; Hamilton M; Guillard S; Ravn P; Minter R; Camara MM; Venkatraman V; Macgill RS; Lin J; Wang Q; Keller AE; Bonnell JC; Tomich M; Jermutus L; McCarthy MP; Melnick DA; Suzich JA; Stover CK J Exp Med; 2012 Jul; 209(7):1273-87. PubMed ID: 22734046 [TBL] [Abstract][Full Text] [Related]
8. Establishment of stable cell lines producing anti-Pseudomonas aeruginosa monoclonal antibodies and their protective effects for the infection in mice. O'Oka H; Chonan E; Mizutani K; Fukuda T; Kuroiwa Y; Ono Y; Shigeta S Microbiol Immunol; 1992; 36(12):1305-16. PubMed ID: 1287405 [TBL] [Abstract][Full Text] [Related]
9. Anti-PcrV antibody strategies against virulent Pseudomonas aeruginosa. Sawa T; Ito E; Nguyen VH; Haight M Hum Vaccin Immunother; 2014; 10(10):2843-52. PubMed ID: 25483637 [TBL] [Abstract][Full Text] [Related]
10. Anti-flagellin IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound murine models in a non-type-specific mode. Ahmadi TS; Mousavi Gargari SL; Talei D Mol Immunol; 2021 Aug; 136():118-127. PubMed ID: 34130152 [TBL] [Abstract][Full Text] [Related]
11. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes. Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231 [TBL] [Abstract][Full Text] [Related]
12. Systematic generation of antigen specific human monoclonal antibodies with therapeutical activities using active immunization. Lang AB; Fürer E; Senyk G; Larrick JW; Cryz SJ Hum Antibodies Hybridomas; 1990; 1(2):96-103. PubMed ID: 2129420 [TBL] [Abstract][Full Text] [Related]
15. Characterization of a human monoclonal antibody to lipopolysaccharides of Pseudomonas aeruginosa serotype 5: a possible candidate as an immunotherapeutic agent for infections with P. aeruginosa. Sawada S; Kawamura T; Masuho Y; Tomibe K J Infect Dis; 1985 Nov; 152(5):965-70. PubMed ID: 3930629 [TBL] [Abstract][Full Text] [Related]
16. Anti-PcrV IgY antibodies protect against Pseudomonas aeruginosa infection in both acute pneumonia and burn wound models. Ranjbar M; Behrouz B; Norouzi F; Mousavi Gargari SL Mol Immunol; 2019 Dec; 116():98-105. PubMed ID: 31634816 [TBL] [Abstract][Full Text] [Related]